Results 1 to 10 of about 60,298 (290)

Chemical vitiligo: A subset of vitiligo

Indian Journal of Dermatology, 2020
Chemical leucoderma, an under-diagnosed common condition often mimicking idiopathic vitiligo, represents an acquired depigmentation induced by repeated exposure to specific chemical compounds in subjects with genetic susceptibility to vitiligo. This has been increasing rapidly in incidence in recent decades in developing countries like India. The term '
Sanjay Ghosh
openalex   +4 more sources

Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. [PDF]

Case Rep Dermatol Med
Parga AD, Dubin C, Rudikoff D.
europepmc   +3 more sources

Vitiligo [PDF]

Nature Reviews Disease Primers, 2015
Vitiligo is an acquired depigmenting disorder that affects 0.5% to 2% of the world population. Three different forms are classified according to the distribution of lesions; namely non-segmental, segmental and mixed vitiligo. Vitiligo is associated with polymorphisms in genes involved in the immune response and in melanogenesis.
Mauro, Picardo, Maria L, Dell'Anna, Khaled, Ezzedine, Iltefat, Hamzavi, John E, Harris, Davinder, Parsad, Alain, Taieb   +6 more
  +7 more sources

Vitiligo

Canadian Medical Association Journal
This review focuses on the characteristics of vitiligo with an emphasis on diagnosis and treatment options. Vitiligo is a chronic skin disease affecting approximately 0.4% of the world’s population. It can lead to stigmatization and a decrease in quality of life. The diagnosis is often straightforward, but there are many other skin conditions which can
Towheed, Shahnawaz, Cy, Ajith
  +7 more sources

Vitiligo and autoimmune thyroid disorders [PDF]

, 2017
Vitiligo represents the most common cause of acquired skin, hair and oral depigmentation, affecting 0.5-1% of the population worldwide. It is clinically characterized by the appearance of disfiguring circumscribed skin macules following melanocyte ...
Baldini, Enke, Carbotta, Giovanni, Catania, Antonio, D'Armiento, Eleonora, Odorisio, Teresa, Persechino, Severino, Pironi, Daniele, Rendina, Roberta, Sorrenti, Salvatore, Tartaglia, Francesco, Ulisse, Salvatore   +10 more
core   +2 more sources

[Vitiligo].

Nederlands tijdschrift voor geneeskunde, 1997
Vitiligo is a disorder in which, owing to disappearance of melanocytes in the skin, sharply delimited, symmetrically arranged white patches develop. The condition occurs in 1-2% of the population, mostly between the ages of 10 and 30 years, and as often in males as in females. The course is usually progressive with periods of stability.
Njoo, M.D., Westerhof, W.
openaire   +5 more sources

Common variants in FOXP1 are associated with generalized vitiligo [PDF]

, 2010
In a recent genome-wide association study of generalized vitiligo, we identified ten confirmed susceptibility loci. By testing additional loci that showed suggestive association in the genome-wide study, using two replication cohorts of European descent,
A Alkhateeb, Alain Taïeb, Andreas Overbeck, Anthony P Weetman, C Shi, Christina M Mailloux, David J Gawkrodger, DF Luo, Dorothy C Bennett, E Helen Kemp, Giovanni Leone, H Hu, HD Ochs, JC Barrett, Jo Lambert, Katherine Gowan, Khaled Ezzedine, Margaret R Wallace, Mauro Picardo, Nanny van Geel, Pamela R Fain, Paulene J Holland, RA Spritz, Richard A Spritz, RM Salazar-Gonzalez, S Horvath, S Purcell, SA Birlea, Sheri L Riccardi, Stanca A Birlea, Thomas Jouary, Wayne T McCormack, X Feng, Y Jin, Ying Jin   +34 more
core   +2 more sources

Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo. [PDF]

, 2010
BACKGROUND Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which results in patchy depigmentation of skin and hair, and is associated with an elevated risk of other autoimmune diseases. METHODS To identify generalized
Alain Taïeb, Alexandra J.D. Sufit, Andreas Overbeck, Anita Amadi-Myers, Anthony P. Weetman, Brand OJ, Christina M. Mailloux, David J. Gawkrodger, Dorothy C. Bennett, E. Helen Kemp, Giovanni Leone, Honda Y, Jo Lambert, Katherine Gowan, Khaled Ezzedine, Margaret R. Wallace, Mauro Picardo, Nanny van Geel, Pamela R. Fain, Paulene J. Holland, Richard A. Spritz, Saunie M. Hutton, Sheri L. Riccardi, Stanca A. Birlea, Thomas Jouary, Tripathi RK, Waerner T, Wang L, Wayne T. McCormack, Ying Jin   +29 more
core   +3 more sources

Emerging Topical and Systemic JAK Inhibitors in Dermatology [PDF]

, 2019
Accumulating data on cellular and molecular pathways help to develop novel therapeutic strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic dermatitis, two clinically and immunologically well-defined disorders.
Ghoreschi, Kamran, Meier, Katharina, Solimani, Farzan   +2 more
core   +1 more source

PHP58 A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro [PDF]

, 2009
Background Punch grafting is a simple and frequently used technique for the treatment of stable vitiligo, resistant to medical therapy. However, studies reporting long-term results are exceptional.
Fongers, A., Krawczyk, P., Nieuweboer-Krobotova, L., Toth, G. G., van der Veen, J. P. W., Wolkerstorfer, A.   +5 more
core   +5 more sources